Trulimax (Azithromycin ) Non-Interventional Study In Acute Bacterial Upper Respiratory Tract Infections

Pfizer

Status: Completed

Conditions: Upper Respiratory Tract Infections

Study type: Observational

Funder types: Industry

Identifiers

NCT00827502

A0661198

Details and patient eligibility

About

To assess effectiveness of Trulimax (Azithromycin) in Acute Bacterial Upper Respiratory Tract Infections (URTIs).

Full description

Prospective, Open-label, Non-interventional and Multi-center Study NA

Enrollment: 421 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Evidence of a personally signed and dated informed consent document indicating that the subject (or a legally acceptable representative) has been informed of all pertinent aspects of the study.
• Patients with acute URTI, presumed to be of bacterial origin as per the clinical judgment of the investigator.

Exclusion criteria

N/A